Actively Recruiting
Prevalence of Opioid Misuse in Patients with Cancer in Danish Palliative Care Units
Led by Rigshospitalet, Denmark · Updated on 2025-03-25
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the risk of opioid misuse among adult cancer patients who are receiving opioids for cancer-related pain. This study focuses on patients in Danish palliative care units and aims to understand how common opioid misuse risk is in this group. The study also explores links between opioid misuse risk and factors such as opioid consumption, use of short-acting opioids, tobacco and alcohol use, prior drug use, and physician reports. Additionally, it examines how opioid misuse risk relates to depression, anxiety, and quality of life. This is a prospective and cross-sectional observational study where opioid misuse is defined as using prescription opioids differently than prescribed, such as using them for reasons other than pain relief or using more than directed. The study uses tools like the Pain Medication Questionnaire (PMQ) and the Opioid Risk Tool (ORT) to assess misuse risk. Other assessments include questionnaires on depression and anxiety (PHQ-4) and quality of life (EORTC-QLQ-C15-PAL). Data on opioid and benzodiazepine use, alcohol and tobacco consumption, and pain characteristics are also collected. Participants will be outpatients aged 18 or older who have cancer-related pain treated with opioids. They will complete questionnaires and assessments at baseline, and follow-up data on opioid misuse information from physicians will be collected one month later. The research measures include the PMQ and ORT scores, pain details, substance use, mental health status, and quality of life. The study does not involve treatment but focuses on collecting and analyzing data to understand opioid misuse risk in this patient population.
CONDITIONS
Brief Title
Opioid Misuse in Patients with Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Outpatients aged 18 years or older
- Patients treated with opioids due to cancer-related pain
You will not qualify if you...
- Patients who do not speak or write Danish
- Patients with severe cognitive dysfunction
- Patients not treated with opioids
- Patients who refuse to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants complete baseline assessments including questionnaires about opioid misuse risk, pain, medication use, mental health, and quality of life.
1 visit (in-person)
Duration - 1 month after baseline
Participants' opioid misuse information is collected based on physician reports 1 month after baseline assessment.
1 follow-up visit (in-person or remote)
Trial Site Locations
Total: 1 location
1
Rigshospitalet
Copenhagen, København Ø., Denmark, 2100
Actively Recruiting
Research Team
G
Geana Kurita, Professor
C
Camilla Lykke, Post. doc
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here